Search - tctmd.com

Displaying 61 - 80 of 314

Sort: Relevancy | Date

News Conference News ISET 2019

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

Caitlin E. Cox

January 31, 2019

News Conference News ISET 2019

Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis

Caitlin E. Cox

January 30, 2019

Presentation ISET 2019

Is CAS largely equivalent to CEA for the majority of patients with significant carotid disease and an indication for revascularization?

Presenter: William A. Gray

January 30, 2019

News Conference News ISET 2019

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Caitlin E. Cox

January 29, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

Podcast TCTMD Talking Points

DES for Femoropopliteal Disease: IMPERIAL

January 09, 2019

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

L.A. McKeown

December 17, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

Presentation VIVA 2018

1-Year Outcomes for Eluvia in Long Lesions

Presenter: William A. Gray

November 09, 2018

News Industry News

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

November 07, 2018

News Conference News VIVA 2018

IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions

L.A. McKeown

November 06, 2018

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Todd Neale

September 24, 2018

News Conference News TCT 2018

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

Todd Neale

September 22, 2018

Presentation TCT 2018

Complications of PFO Closure

Presenter: William A. Gray, Horst Sievert, Jacqueline Saw

September 22, 2018

Presentation TCT 2018

PFO Closure With the Amplatzer PFO Occluder: Device Description, Ideal and Non-Ideal Anatomy, Technique, and Complications

Presenter: William A. Gray, Horst Sievert, Eric Horlick

September 22, 2018

Presentation TCT 2018

PFO Closure With the CardioForm: Device Description, Ideal and Non-Ideal Anatomy, Technique, and Complications

Presenter: William A. Gray, Horst Sievert, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

The Landscape of Devices for PFO Closure

Presenter: William A. Gray, Horst Sievert

September 22, 2018

Presentation TCT 2018

Approach to Challenging PFO Anatomy

Presenter: William A. Gray, Horst Sievert, Zahid Amin

September 22, 2018

Presentation TCT 2018

Assessment of Shunts: TCD vs Echo

Presenter: William A. Gray, Horst Sievert, Eustaquio Maria Onorato

September 22, 2018

Presentation TCT 2018

Case #3: A Complex PFO Closure With Technique Challenges

Presenter: William A. Gray, Horst Sievert, Steven R. Bailey, Nirat Beohar, Brian Clapp, Eric Eeckhout, Franz X. Kleber, Lars Sondergaard

September 22, 2018

Advertisement

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis

Is CAS largely equivalent to CEA for the majority of patients with significant carotid disease and an indication for revascularization?

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

DES for Femoropopliteal Disease: IMPERIAL

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

1-Year Outcomes for Eluvia in Long Lesions

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

Complications of PFO Closure

PFO Closure With the Amplatzer PFO Occluder: Device Description, Ideal and Non-Ideal Anatomy, Technique, and Complications

PFO Closure With the CardioForm: Device Description, Ideal and Non-Ideal Anatomy, Technique, and Complications

The Landscape of Devices for PFO Closure

Approach to Challenging PFO Anatomy

Assessment of Shunts: TCD vs Echo

Case #3: A Complex PFO Closure With Technique Challenges

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content